# SPOCK1

## Overview
SPOCK1, also known as Testican-1, is a gene that encodes a proteoglycan involved in various cellular processes, particularly within the extracellular matrix (ECM). The protein encoded by SPOCK1 is characterized by its complex structure, which includes domains such as a follistatin-like domain, a calcium-binding domain, and a Kazal-type serine protease inhibitor domain, contributing to its functional diversity and interaction capabilities. As a proteoglycan, SPOCK1 plays a crucial role in cell adhesion, migration, and proliferation, influencing tissue remodeling and repair. It is expressed in multiple tissues, including the brain, cartilage, and vascular endothelium, and is involved in physiological functions such as nervous system development and adipocyte differentiation. SPOCK1's interactions with various proteins and signaling pathways, such as the PI3K/Akt pathway, underscore its significance in both normal cellular functions and pathological conditions, including cancer progression and metastasis (Han2021Multiomic; Alshargabi2020SPOCK1; Xiao2024SPOCK:).

## Structure
SPOCK1, also known as Testican-1, is a proteoglycan characterized by a complex molecular structure that facilitates its role in cell-matrix interactions. The primary structure of SPOCK1 includes a signal peptide, which directs the nascent protein to the secretory pathway, a follistatin-like domain, a calcium-binding domain, and a C-terminal Kazal-type serine protease inhibitor domain. These domains contribute to the protein's functional diversity and interaction capabilities.

The secondary structure of SPOCK1 features both beta-sheets and alpha-helices, which are common structural motifs that contribute to the protein's stability and functional conformation. The presence of these elements suggests a well-organized three-dimensional structure that is crucial for its biological activity.

Post-translational modifications of SPOCK1 include glycosylation, a process that can influence protein folding, stability, and interactions with other molecules. Glycosylation is a significant modification that affects the protein's function and its interaction with the extracellular matrix.

While the context does not provide specific details on the tertiary and quaternary structures, the described domains and modifications imply a sophisticated architecture that supports SPOCK1's role in cellular processes. The combination of these structural features underlines the importance of SPOCK1 in maintaining cellular and extracellular matrix integrity.

## Function
SPOCK1, also known as Testican-1, is a proteoglycan that plays a significant role in various cellular processes, particularly within the extracellular matrix (ECM). It is involved in cell adhesion, migration, and proliferation, contributing to tissue remodeling and repair. SPOCK1 interacts with other matrix components and enzymes, influencing the structural integrity and function of tissues (Xiao2024SPOCK:).

In healthy human cells, SPOCK1 is expressed in multiple tissues, including the brain, cartilage, vascular endothelium, and neuromuscular junctions, indicating its involvement in diverse physiological functions (Alshargabi2020SPOCK1). It is highly expressed in the human brain, particularly in the thalamus, where it plays a crucial role in nervous system development, axonal growth, and synaptic plasticity (Xiao2024SPOCK:). SPOCK1 is also involved in adipocyte differentiation and metabolism, enhancing the expression of key adipogenesis-related genes, which are essential for adipocyte maturation and lipid accumulation (Alshargabi2020SPOCK1).

SPOCK1's molecular activities include functioning as a competitive inhibitor of cathepsin L, independent of its glycosaminoglycan chains, and it is known to localize in mitochondria, suggesting a potential role in mitochondrial function (Váncza2022SPOCK1; Xiao2024SPOCK:). Despite its low expression in healthy liver cells, its presence in the cytoplasm and mitochondria hints at a physiological role that is not yet fully understood (Váncza2022SPOCK1).

## Clinical Significance
SPOCK1 is implicated in various cancers, where its altered expression is associated with tumor progression and poor prognosis. In breast cancer, particularly invasive ductal carcinoma (IDC), SPOCK1 expression is linked to larger tumor size, higher histological grade, and specific aggressive phenotypes such as triple-negative and basal-like. Its expression correlates with poorer overall survival, suggesting its potential as a prognostic marker (Fan2016SPOCK1). In ovarian cancer, SPOCK1 overexpression is associated with poor prognosis, especially in early-stage tumors, and is linked to chemotherapy resistance (Váncza2023SPOCK1). 

In glioma, SPOCK1 acts as an oncogene, promoting cell proliferation, migration, and invasion through the PI3K/AKT and Wnt/β-catenin signaling pathways. Its overexpression enhances tumor growth and inhibits apoptosis, indicating its role in glioma progression (YANG2016SPOCK1). SPOCK1 is also involved in colorectal cancer, where it is associated with poor survival and advanced disease stages. The miR-135b/SPOCK1 axis influences tumor metabolism and growth, presenting a potential therapeutic target (Babaei-Jadidi2022Anti-miR-135/SPOCK1). 

In gallbladder cancer, SPOCK1 promotes proliferation and metastasis by activating the PI3K/Akt pathway, and its expression correlates with poor survival outcomes (Shu2015SPOCK1). In prostate cancer, SPOCK1 overexpression is linked to poor prognosis and shorter disease-free survival (Chien2019Targeting).

## Interactions
SPOCK1, also known as testican-1, is involved in various interactions with proteins and nucleic acids that influence cancer progression. It physically interacts with the GTF2E2 and TNF genes, indicating its role in transcriptional regulation and inflammatory responses (Han2021Multiomic). SPOCK1 is also part of a protein network that includes CHD1L, CGREF1, SERTM1, MMP14, MMP16, SPARC, SMOC1, TG, STS, and SPARCL1, as identified through STRING database analysis (Han2021Multiomic). 

In hepatocellular carcinoma, SPOCK1 is regulated by the transcription factor CHD1L, which binds directly to its promoter region, enhancing its transcription (Li2013SPOCK1). This interaction is crucial for SPOCK1's role in activating the Akt signaling pathway, which prevents apoptosis and promotes cell survival and invasiveness (Li2013SPOCK1). SPOCK1 also interacts with the PI3K/Akt pathway, influencing the epithelial-to-mesenchymal transition (EMT) process by regulating transcription factors such as Snail and Slug, which are critical for cancer cell invasion and metastasis (Sun2020&lt; p&gt; SPOCK1; Chien2019Targeting). These interactions highlight SPOCK1's involvement in key signaling pathways that drive tumor progression and metastasis.


## References


[1. (Alshargabi2020SPOCK1) Rehab Alshargabi, Takanori Shinjo, Misaki Iwashita, Akiko Yamashita, Tomomi Sano, Yuki Nishimura, Masato Hayashi, Tatsuro Zeze, Takao Fukuda, Terukazu Sanui, and Fusanori Nishimura. Spock1 induces adipose tissue maturation: new insights into the function of spock1 in metabolism. Biochemical and Biophysical Research Communications, 533(4):1076–1082, December 2020. URL: http://dx.doi.org/10.1016/j.bbrc.2020.09.129, doi:10.1016/j.bbrc.2020.09.129. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2020.09.129)

[2. (Chien2019Targeting) Ming-Hsien Chien, Yung-Wei Lin, Yu-Ching Wen, Yi-Chieh Yang, Michael Hsiao, Junn-Liang Chang, Hsiang-Ching Huang, and Wei-Jiunn Lee. Targeting the spock1-snail/slug axis-mediated epithelial-to-mesenchymal transition by apigenin contributes to repression of prostate cancer metastasis. Journal of Experimental &amp; Clinical Cancer Research, June 2019. URL: http://dx.doi.org/10.1186/s13046-019-1247-3, doi:10.1186/s13046-019-1247-3. This article has 54 citations.](https://doi.org/10.1186/s13046-019-1247-3)

[3. (Shu2015SPOCK1) Yi-Jun Shu, Hao Weng, Yuan-Yuan Ye, Yun-Ping Hu, Run-Fa Bao, Yang Cao, Xu-An Wang, Fei Zhang, Shan-Shan Xiang, Huai-Feng Li, Xiang-Song Wu, Mao-Lan Li, Lin Jiang, Wei Lu, Bao-San Han, Zhi-Gang Jie, and Ying-Bin Liu. Spock1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the pi3k/akt pathway. Molecular Cancer, January 2015. URL: http://dx.doi.org/10.1186/s12943-014-0276-y, doi:10.1186/s12943-014-0276-y. This article has 88 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/s12943-014-0276-y)

[4. (Xiao2024SPOCK:) Mingyuan Xiao, Jiancheng Xue, and Enli Jin. Spock: master regulator of malignant tumors (review). Molecular Medicine Reports, October 2024. URL: http://dx.doi.org/10.3892/mmr.2024.13355, doi:10.3892/mmr.2024.13355. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/mmr.2024.13355)

[5. (Váncza2022SPOCK1) Lóránd Váncza, Katalin Karászi, Bálint Péterfia, Lilla Turiák, Katalin Dezső, Anna Sebestyén, Andrea Reszegi, Gábor Petővári, András Kiss, Zsuzsanna Schaff, Kornélia Baghy, and Ilona Kovalszky. Spock1 promotes the development of hepatocellular carcinoma. Frontiers in Oncology, February 2022. URL: http://dx.doi.org/10.3389/fonc.2022.819883, doi:10.3389/fonc.2022.819883. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2022.819883)

[6. (Fan2016SPOCK1) Li-Ching Fan, Yung-Ming Jeng, Yueh-Tong Lu, and Huang-Chun Lien. Spock1 is a novel transforming growth factor-β–induced myoepithelial marker that enhances invasion and correlates with poor prognosis in breast cancer. PLOS ONE, 11(9):e0162933, September 2016. URL: http://dx.doi.org/10.1371/journal.pone.0162933, doi:10.1371/journal.pone.0162933. This article has 28 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0162933)

[7. (YANG2016SPOCK1) JINGHUI YANG, QIWEI YANG, JING YU, XIMENG LI, SHAN YU, and XUEWEN ZHANG. Spock1 promotes the proliferation, migration and invasion of glioma cells through pi3k/akt and wnt/β-catenin signaling pathways. Oncology Reports, 35(6):3566–3576, April 2016. URL: http://dx.doi.org/10.3892/or.2016.4757, doi:10.3892/or.2016.4757. This article has 53 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/or.2016.4757)

[8. (Han2021Multiomic) Jie Han, Yihui Rong, and Xudong Gao. Multiomic analysis of the function of spock1 across cancers: an integrated bioinformatics approach. Journal of International Medical Research, June 2021. URL: http://dx.doi.org/10.1177/0300060520962659, doi:10.1177/0300060520962659. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1177/0300060520962659)

[9. (Li2013SPOCK1) Yan Li, Leilei Chen, Tim Hon Man Chan, Ming Liu, Kar–Lok Kong, Ji–Liang Qiu, Yan Li, Yun–Fei Yuan, and Xin–Yuan Guan. Spock1 is regulated by chd1l and blocks apoptosis and promotes hcc cell invasiveness and metastasis in mice. Gastroenterology, 144(1):179-191.e4, January 2013. URL: http://dx.doi.org/10.1053/j.gastro.2012.09.042, doi:10.1053/j.gastro.2012.09.042. This article has 76 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1053/j.gastro.2012.09.042)

[10. (Váncza2023SPOCK1) Lóránd Váncza, Anna Horváth, Lee Seungyeon, András Rókusz, Katalin Dezső, Andrea Reszegi, Gábor Petővári, Martin Götte, Ilona Kovalszky, and Kornélia Baghy. Spock1 overexpression suggests poor prognosis of ovarian cancer. Cancers, 15(7):2037, March 2023. URL: http://dx.doi.org/10.3390/cancers15072037, doi:10.3390/cancers15072037. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers15072037)

[11. (Babaei-Jadidi2022Anti-miR-135/SPOCK1) Roya Babaei-Jadidi, Hossein Kashfi, Walla Alelwani, Ashkan Karimi Bakhtiari, Shahad W. Kattan, Omniah A. Mansouri, Abhik Mukherjee, Dileep N. Lobo, and Abdolrahman S. Nateri. Anti-mir-135/spock1 axis antagonizes the influence of metabolism on drug response in intestinal/colon tumour organoids. Oncogenesis, January 2022. URL: http://dx.doi.org/10.1038/s41389-021-00376-1, doi:10.1038/s41389-021-00376-1. This article has 7 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41389-021-00376-1)